APA (7th ed.) Citation

T, P., SS, S., Y, L., J, B., XJ, M., KA, C., . . . CB, D. (2021). Avelumab maintenance in advanced urothelial carcinoma: Biomarker analysis of the phase 3 JAVELIN Bladder 100 trial. Nature medicine, 27(12), 2200. https://doi.org/10.1038/s41591-021-01579-0

Chicago Style (17th ed.) Citation

T, Powles, et al. "Avelumab Maintenance in Advanced Urothelial Carcinoma: Biomarker Analysis of the Phase 3 JAVELIN Bladder 100 Trial." Nature Medicine 27, no. 12 (2021): 2200. https://doi.org/10.1038/s41591-021-01579-0.

MLA (9th ed.) Citation

T, Powles, et al. "Avelumab Maintenance in Advanced Urothelial Carcinoma: Biomarker Analysis of the Phase 3 JAVELIN Bladder 100 Trial." Nature Medicine, vol. 27, no. 12, 2021, p. 2200, https://doi.org/10.1038/s41591-021-01579-0.